🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07163767
Active, not recruiting Observational

Acute Myocardial Infarction Prediction Using Artificial Intelligence Applied to Electrocardiogram Images

NCT07163767 · tracked via the Priya Life Science China tracker
Sponsor
Guangdong Provincial People's Hospital
Phase
Observational
Started
2025-08-01
Last updated
2025-12-18

Condition(s) studied

Acute Myocardial Infarction (AMI)ElectrocardiographyArtifical Intelligence

Investigational drug(s) / intervention(s)

Deep learning approach of ECG for AMI detection

Deep learning approach of ECG for AMI detection: AMIdECG was trained to perform AMI detection in a supervised manner as a classification task. And the classification labels of AMI subtypes (" STEMI "or" NSTEMI ") or non-AMI states used during the training phase are real-world diagnostic results

Study summary

The goal of this observational study is to develop and validate an artificial intelligence(AI)-based prediction model for new-onset acute myocardial infarction(AMI) using electrocardiogram(ECG) data. The main question it aims to answer is whether the AI-based ECG accurately forecast new-onset AMI by previous ECG data with 'normal' diagnosis?

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Hospitalized in cardiology department with myocardial injury marker testing (troponin T/I). * In-hospital patients with ECG records. Exclusion Criteria: * First ECG obtained in emergency department. * ACS diagnosis within 1 month of first ECG.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Guangdong Provincial People's Hospital Guangzhou Guangdong

More Guangdong Provincial People's Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07163767 on ClinicalTrials.gov ↗ ← All trials in China